BNP Paribas Financial Markets Lowers Holdings in Bio-Rad Laboratories, Inc. (NYSE:BIO)
BNP Paribas Financial Markets trimmed its holdings in Bio-Rad Laboratories, Inc. (NYSE:BIO – Free Report) by 10.6% in the 4th quarter, HoldingsChannel reports. The fund owned 7,548 shares of the medical research company’s stock after selling 896 shares during the quarter. BNP Paribas Financial Markets’ holdings in Bio-Rad Laboratories were worth $2,480,000 at the end […]
